Bo Wang, MD

Articles by Bo Wang, MD

Bo Wang, MDNon-Small Cell Lung Cancer | November 6, 2023

Drs. Bo Wang and Sheena Bhalla discuss the EVOKE-02 study, which assessed sacituzumab govitecan plus pembrolizumab in NSCLC.